AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Laviglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Lavish Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Laviglim M 1mg/500mg Tablet SR

Glucovance SR, a 1mg/500mg combination tablet, is classified as an antidiabetic medication. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Glucovance SR with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication as prescribed, even with controlled blood sugar; discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medicine forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.

Uses of Laviglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Laviglim M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Laviglim M 1mg/500mg Tablet SR with a meal.

Common Side effects of Laviglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Laviglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Laviglim M 1mg/500mg Sustained-Release tablet with a meal.

How Laviglim M 1mg/500mg Tablet SR works:

Laviglim M SR tablets (1mg/500mg) combine glimepiride and metformin, two medications for diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Laviglim M 1mg/500mg SR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Laviglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Laviglim M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Laviglim M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. For patients experiencing severe kidney disease, Laviglim M 1mg/500mg SR tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Laviglim M 1mg/500mg Tablet SR, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a reduced Laviglim M 1mg/500mg Tablet SR dosage. However, its use is contraindicated in patients with severe hepatic dysfunction. Medical advice is recommended.

What if you forget to take Laviglim M 1mg/500mg Tablet SR :

Should you forget a dose of your Laviglim M 1mg/500mg SR Tablet, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Laviglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Laviglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Laviglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Laviglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Laviglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Laviglim M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Laviglim M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Laviglim M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Laviglim M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Laviglim M 1mg/500mg Tabl...
41
MRP 50
18% off